Preclinical evaluation of novel mesothelin-specific ligands for SPECT imaging of Triple Negative Breast Cancer.
about
Preclinical evaluation of novel mesothelin-specific ligands for SPECT imaging of Triple Negative Breast Cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Preclinical evaluation of nove ...... Triple Negative Breast Cancer.
@en
Preclinical evaluation of nove ...... Triple Negative Breast Cancer.
@nl
type
label
Preclinical evaluation of nove ...... Triple Negative Breast Cancer.
@en
Preclinical evaluation of nove ...... Triple Negative Breast Cancer.
@nl
prefLabel
Preclinical evaluation of nove ...... Triple Negative Breast Cancer.
@en
Preclinical evaluation of nove ...... Triple Negative Breast Cancer.
@nl
P2093
P50
P1476
Preclinical Evaluation of Meso ...... Triple-Negative Breast Cancer
@en
P2093
Audrey Soubies
Brigitte Kerfelec
Catherine Ghezzi
Christopher Montemagno
Daniel Baty
Daniel Fagret
Marlene Debiossat
Pascale Perret
Sandrine Bacot
P304
P356
10.2967/JNUMED.117.203489
P407
P577
2018-03-23T00:00:00Z